The GLP-1 wave is not limited to current users. Three distinct profiles are emerging, each with specific nutritional needs — and each representing a real opportunity for the food & beverage industry.

Across all three profiles, a clear pattern emerges: reduced intake does not mean reduced expectations. Consumers want foods that deliver more value per bite.

Muscle preservation

Smaller portions increase the risk of insufficient protein intake. High-quality, bioavailable protein is essential to maintain lean body mass during caloric restriction.

Digestive comfort

GLP-1 therapy frequently causes side effects — nausea, bloating, constipation. Gentle, prebiotic-rich fibre helps restore digestive balance and ease the transition across all phases of the journey.

The fibre gap

When meal volumes shrink, dietary fibre is one of the first casualties. Yet fibre plays a central role in satiety, gut health and blood glucose regulation — three priorities that matter more, not less, when eating less. Gradual, well-tolerated fibre intake adapted to smaller portions is key to long-term adherence.

Micronutrient density

Reduced food variety and volume lead to shortfalls in fibre, iron, calcium, magnesium, vitamins A, C, D, E & B12. Every ingredient must deliver more.

Formulation

Delivering complete nutrition in smaller volumes requires rethinking density, texture and tolerance. Softer textures, milder flavours and lower glycaemic profiles are becoming new baselines.

Market opportunity

Households on GLP-1 therapies are shifting spend: -10% on groceries & fast food, +38% on protein shakes, +58% on superfoods (Numerator, 2025). Reformulated products placed alongside core ranges can reach both GLP-1 users and health-conscious shoppers.

Regulatory compliance

In Europe, claims like “GLP-1 friendly” are legally prohibited. Brands must communicate nutritional benefits through authorised health claims — and remain focused on nutritional messaging rather than medical claims.

Addressing weight management issues

Addressing weight management, as well as maintaining overall health, includes approaches such as intermittent fasting, keto dieting, or substituting healthier products for snacks to curb cravings.

The combination of PISANE™ pea protein and FIBRULINE™ & FIBRULOSE™ chicory root fibre enables formulation of nutrient-dense, portion-controlled, easy-to-digest products — aligned with the sensory and nutritional needs of weight-management consumers.

PISANE™ pea protein

High-quality plant protein (Amino Acid Score 0.96), with 98% digestibility and high BCAA content — particularly Leucine (8.4g/100g of protein).

✔ Supports muscle maintenance during caloric restriction*

✔ Promotes satiety and dietary adherence

✔ Neutral taste — easy to incorporate

✔ Clinically studied (pea protein & post-exercise muscle synthesis, 2023)

Recommended protein intake during weight loss: 1.2–1.6 g/kg/day, distributed across meals.

FIBRULINE™ & FIBRULOSE™ chicory root fibre

Naturally sourced soluble prebiotic fibre from chicory root

✔ Supports normal bowel function by increasing stool frequency** (12g/day)

✔ Nourishes beneficial gut bacteria — supports balanced microbiota

✔ Helps close the dietary fibre gap

✔ Low-calorie bulking agent — replaces high-glycaemic carbohydrates

✔ Fermentation produces SCFAs involved in appetite regulation

Gradual introduction, adapted to smaller portions and paired with adequate hydration, ensures digestive tolerance.